Bliss GVS Pharma Limited
BLISSGVS.NS

$161.98 M
Marketcap
$1.54
Share price
Country
$0.10
Change (1 day)
$1.77
Year High
$1.09
Year Low

Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company also provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes. In addition, it offers therapeutic products consisting of anti-bacterial, anti-dandruff shampoo, amino acid preparation, iron tonic, antitussive, appetite stimulant, anti-allergic, body supplement, anti-biotic, anti-diabetic, anti-diarrheal, anti-emetic, anti-fungal, anti-haemorrhoidal, anti-helmintic, anti-infective, anti-inflammatory, anti-malarial, anti-microbial, anti-migraine, anti-oxidant, anti-protozoal, ear wax solvent, anti-pyretic, anti-septic, anti-spasmodic, anti-ulcer, and anti-ulcerant; and analgesic, oral rehydration, antacid, anxiolytic, appetizer, cough syrup, erectile dysfunction, haematinic, hand sanitizer, health supplement, insecticide, laryngitis, pharyngitis, laxative, lubricant, mosquito repellant, nasal decongestant, nutritional supplement, moisturizer, prickly heat powder, skin lightening lotion, vaginal contraceptive, vaginal hygiene, and vitamin supplements, as well as medicated, complexion, moisturizing, and total protection soaps. The company also exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.

marketcap

P/E ratio for Bliss GVS Pharma Limited (BLISSGVS.NS)

P/E ratio as of 2023: 16.05

According to Bliss GVS Pharma Limited's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 16.05. At the end of 2022 the company had a P/E ratio of 10.42.

P/E ratio history for Bliss GVS Pharma Limited from 2006 to 2023

PE ratio at the end of each year

Year P/E ratio
2023 16.05
2022 10.42
2021 52.97
2020 14.84
2019 10.68
2018 15.03
2017 34.65
2016 21.28
2015 15.69
2014 22.16
2013 11.32
2012 5.31
2011 4.53
2010 5.71
2009 10.09
2008 11.24
2007 19.96
2006 6.25